Cite
HARVARD Citation
Vincken, W. et al. (n.d.). P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study. Thorax. pp. A181-A182. [Online].